Gaurav Shah, CEO at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 40,544 shares at $29.84 ($1.2M) on 2024-02-16, disclosed to the SEC on 2024-02-21.
Open-market sale of $1.2M RCKT by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.84 | 20,272 | $605K | 50.0% |
| 2 | $29.84 | 20,272 | $605K | 50.0% |
| Total | $29.84 avg | 40,544 | $1.2M | 100% |
| Filing → |
| RCKT | SELL | 2026-05-26 | $172K | — | Filing → |
| RCKT | SELL | 2026-05-21 | $7K | — | Filing → |
| RCKT | SELL | 2026-05-14 | $10K | — | Filing → |